vs

Side-by-side financial comparison of Apyx Medical Corp (APYX) and C & F FINANCIAL CORP (CFFI). Click either name above to swap in a different company.

C & F FINANCIAL CORP is the larger business by last-quarter revenue ($35.9M vs $19.2M, roughly 1.9× Apyx Medical Corp). C & F FINANCIAL CORP runs the higher net margin — 18.7% vs -6.8%, a 25.5% gap on every dollar of revenue. On growth, Apyx Medical Corp posted the faster year-over-year revenue change (34.7% vs 12.0%). C & F FINANCIAL CORP produced more free cash flow last quarter ($22.2M vs $-2.8M). Over the past eight quarters, Apyx Medical Corp's revenue compounded faster (36.8% CAGR vs 8.2%).

Bovie Medical Corporation was an American medical device manufacturer of medical devices, electrosurgical products and energy technologies. It was based in Clearwater, Florida with a manufacturing facility in Bulgaria.

Sun Life Financial Inc. is a Canadian financial services company headquartered in Toronto, Ontario. Founded in 1865, it operates internationally in life insurance, wealth management, and asset management. As of 2024, the company manages over CAD$1.3 trillion in assets and serves clients in Canada, the United States, Asia, and other markets.

APYX vs CFFI — Head-to-Head

Bigger by revenue
CFFI
CFFI
1.9× larger
CFFI
$35.9M
$19.2M
APYX
Growing faster (revenue YoY)
APYX
APYX
+22.8% gap
APYX
34.7%
12.0%
CFFI
Higher net margin
CFFI
CFFI
25.5% more per $
CFFI
18.7%
-6.8%
APYX
More free cash flow
CFFI
CFFI
$25.0M more FCF
CFFI
$22.2M
$-2.8M
APYX
Faster 2-yr revenue CAGR
APYX
APYX
Annualised
APYX
36.8%
8.2%
CFFI

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
APYX
APYX
CFFI
CFFI
Revenue
$19.2M
$35.9M
Net Profit
$-1.3M
$6.7M
Gross Margin
62.6%
Operating Margin
0.1%
22.6%
Net Margin
-6.8%
18.7%
Revenue YoY
34.7%
12.0%
Net Profit YoY
71.9%
11.0%
EPS (diluted)
$2.08

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
APYX
APYX
CFFI
CFFI
Q4 25
$19.2M
$35.9M
Q3 25
$12.9M
$36.0M
Q2 25
$11.4M
$36.4M
Q1 25
$9.4M
$32.6M
Q4 24
$14.2M
$32.0M
Q3 24
$11.5M
$33.5M
Q2 24
$12.1M
$31.2M
Q1 24
$10.2M
$30.6M
Net Profit
APYX
APYX
CFFI
CFFI
Q4 25
$-1.3M
$6.7M
Q3 25
$-2.0M
$7.1M
Q2 25
$-3.8M
$7.7M
Q1 25
$-4.2M
$5.4M
Q4 24
$-4.6M
$6.0M
Q3 24
$-4.7M
$5.4M
Q2 24
$-6.6M
$5.0M
Q1 24
$-7.6M
$3.4M
Gross Margin
APYX
APYX
CFFI
CFFI
Q4 25
62.6%
Q3 25
64.4%
Q2 25
62.3%
Q1 25
60.1%
Q4 24
63.0%
Q3 24
60.5%
Q2 24
61.7%
Q1 24
58.1%
Operating Margin
APYX
APYX
CFFI
CFFI
Q4 25
0.1%
22.6%
Q3 25
-6.5%
24.5%
Q2 25
-22.6%
26.5%
Q1 25
-32.4%
20.0%
Q4 24
-21.4%
22.6%
Q3 24
-31.6%
19.9%
Q2 24
-45.7%
20.0%
Q1 24
-64.6%
13.1%
Net Margin
APYX
APYX
CFFI
CFFI
Q4 25
-6.8%
18.7%
Q3 25
-15.4%
19.6%
Q2 25
-33.2%
21.2%
Q1 25
-44.0%
16.5%
Q4 24
-32.5%
18.8%
Q3 24
-40.9%
16.1%
Q2 24
-54.0%
16.1%
Q1 24
-74.0%
11.1%
EPS (diluted)
APYX
APYX
CFFI
CFFI
Q4 25
$2.08
Q3 25
$2.18
Q2 25
$2.37
Q1 25
$1.66
Q4 24
$1.85
Q3 24
$1.65
Q2 24
$-0.19
$1.50
Q1 24
$-0.22
$1.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
APYX
APYX
CFFI
CFFI
Cash + ST InvestmentsLiquidity on hand
$31.7M
Total DebtLower is stronger
$37.5M
Stockholders' EquityBook value
$14.5M
$261.8M
Total Assets
$66.8M
$2.8B
Debt / EquityLower = less leverage
2.58×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
APYX
APYX
CFFI
CFFI
Q4 25
$31.7M
Q3 25
$25.1M
Q2 25
$29.3M
Q1 25
$31.0M
Q4 24
$31.7M
Q3 24
$28.0M
Q2 24
$32.7M
Q1 24
$37.3M
Total Debt
APYX
APYX
CFFI
CFFI
Q4 25
$37.5M
Q3 25
$37.5M
Q2 25
$37.5M
Q1 25
$37.5M
Q4 24
$37.5M
Q3 24
$37.5M
Q2 24
Q1 24
Stockholders' Equity
APYX
APYX
CFFI
CFFI
Q4 25
$14.5M
$261.8M
Q3 25
$5.8M
$253.3M
Q2 25
$7.3M
$240.3M
Q1 25
$10.5M
$234.6M
Q4 24
$14.2M
$226.4M
Q3 24
$11.0M
$227.3M
Q2 24
$14.7M
$218.5M
Q1 24
$20.3M
$216.3M
Total Assets
APYX
APYX
CFFI
CFFI
Q4 25
$66.8M
$2.8B
Q3 25
$57.4M
$2.7B
Q2 25
$58.2M
$2.7B
Q1 25
$60.2M
$2.6B
Q4 24
$64.8M
$2.6B
Q3 24
$60.7M
$2.6B
Q2 24
$65.4M
$2.5B
Q1 24
$70.7M
$2.5B
Debt / Equity
APYX
APYX
CFFI
CFFI
Q4 25
2.58×
Q3 25
6.41×
Q2 25
5.17×
Q1 25
3.57×
Q4 24
2.64×
Q3 24
3.40×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
APYX
APYX
CFFI
CFFI
Operating Cash FlowLast quarter
$-2.5M
$24.5M
Free Cash FlowOCF − Capex
$-2.8M
$22.2M
FCF MarginFCF / Revenue
-14.6%
61.8%
Capex IntensityCapex / Revenue
1.4%
6.5%
Cash ConversionOCF / Net Profit
3.65×
TTM Free Cash FlowTrailing 4 quarters
$-9.1M
$42.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
APYX
APYX
CFFI
CFFI
Q4 25
$-2.5M
$24.5M
Q3 25
$-3.5M
$23.4M
Q2 25
$-1.2M
$-4.4M
Q1 25
$-702.0K
$3.2M
Q4 24
$-2.9M
$36.8M
Q3 24
$-4.4M
$404.0K
Q2 24
$-4.3M
$1.7M
Q1 24
$-6.3M
$895.0K
Free Cash Flow
APYX
APYX
CFFI
CFFI
Q4 25
$-2.8M
$22.2M
Q3 25
$-4.1M
$22.7M
Q2 25
$-1.5M
$-5.0M
Q1 25
$-757.0K
$2.9M
Q4 24
$-3.2M
$33.3M
Q3 24
$-4.6M
$-1.6M
Q2 24
$-4.6M
$1.2M
Q1 24
$-6.4M
$410.0K
FCF Margin
APYX
APYX
CFFI
CFFI
Q4 25
-14.6%
61.8%
Q3 25
-31.5%
63.0%
Q2 25
-13.2%
-13.6%
Q1 25
-8.0%
9.0%
Q4 24
-22.4%
103.8%
Q3 24
-40.0%
-4.9%
Q2 24
-38.0%
3.7%
Q1 24
-62.2%
1.3%
Capex Intensity
APYX
APYX
CFFI
CFFI
Q4 25
1.4%
6.5%
Q3 25
4.0%
2.1%
Q2 25
2.3%
1.6%
Q1 25
0.6%
0.8%
Q4 24
1.7%
10.9%
Q3 24
1.3%
6.1%
Q2 24
2.4%
1.7%
Q1 24
0.3%
1.6%
Cash Conversion
APYX
APYX
CFFI
CFFI
Q4 25
3.65×
Q3 25
3.31×
Q2 25
-0.57×
Q1 25
0.60×
Q4 24
6.09×
Q3 24
0.07×
Q2 24
0.34×
Q1 24
0.26×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

APYX
APYX

Segment breakdown not available.

CFFI
CFFI

Community Banking$25.9M72%
Consumer Finance Segment$7.0M19%
Mortgage Banking Segment$1.9M5%
Other$1.1M3%

Related Comparisons